Literature DB >> 21193961

Role of Bruton's tyrosine kinase in macrophage apoptosis.

Anupriya Khare1, Bharathi Viswanathan, Rupali Gund, Nidhi Jain, Balachandran Ravindran, Anna George, Satyajit Rath, Vineeta Bal.   

Abstract

Macrophages and polymorphonuclear cells (PMNs) rapidly respond to microbial and immune inflammatory stimuli and die during these responses. We have shown earlier that many macrophage and PMN functions are compromised in x-linked immunodeficient (Xid) mice with functional deficiency in Bruton's tyrosine kinase (Btk). We now report that Btk-deficient macrophages show enhanced susceptibility to apoptotic death on exposure to the microbial and immune inflammatory signals bacterial lipopolysaccharide (LPS) and interferon-gamma (IFNγ) in vitro. In vivo in mixed bone marrow (BM) chimeras Btk deficiency leads primarily to loss of peripheral macrophage numbers without affecting BM development, suggesting a role of inflammation-induced apoptosis in regulating macrophage life span. Surprisingly, Btk deficiency does not affect macrophage apoptosis induced by DNA damage or CD95 engagement. Reactive nitrogen and oxygen species also do not contribute to inflammation-induced apoptosis, but apoptotic process involves loss of mitochondrial potential, shows increased activation of caspase 9 and enhanced loss of Bcl-xL. The lack of pro-survival signaling through the Btk-phosphotidylinositol 3-kinase-Akt pathway, and persistent MEK signaling, lead to enhanced death in Btk-deficient macrophages only downstream of inflammatory triggers. These data underline the complex role of Btk in the regulation of macrophage survival and function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21193961     DOI: 10.1007/s10495-010-0569-6

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  6 in total

1.  Ibrutinib Exacerbates Bleomycin-Induced Pulmonary Fibrosis via Promoting Inflammation.

Authors:  Yangyang Gu; Bo Huang; Yanfei Yang; Mengdie Qi; Guohua Lu; Dajing Xia; Hequan Li
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

2.  CD11c identifies microbiota and EGR2-dependent MHCII+ serous cavity macrophages with sexually dimorphic fate in mice.

Authors:  Calum C Bain; Pieter A Louwe; Nicholas J Steers; Alberto Bravo-Blas; Lizi M Hegarty; Clare Pridans; Simon W F Milling; Andrew S MacDonald; Dominik Rückerl; Stephen J Jenkins
Journal:  Eur J Immunol       Date:  2022-05-24       Impact factor: 6.688

3.  Tyrosine kinase Btk is required for NK cell activation.

Authors:  Yan Bao; Jian Zheng; Chaofeng Han; Jing Jin; Huanxing Han; Yinping Liu; Yu-Lung Lau; Wenwei Tu; Xuetao Cao
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

Review 4.  How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD.

Authors:  Samantha M Jaglowski; Bruce R Blazar
Journal:  Blood Adv       Date:  2018-08-14

5.  Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor.

Authors:  W Guo; R Liu; G Bhardwaj; J C Yang; C Changou; A-H Ma; A Mazloom; S Chintapalli; K Xiao; W Xiao; P Kumaresan; E Sanchez; C-T Yeh; C P Evans; R Patterson; K S Lam; H-J Kung
Journal:  Cell Death Dis       Date:  2014-09-04       Impact factor: 8.469

6.  Suppression of Adaptive Immune Cell Activation Does Not Alter Innate Immune Adipose Inflammation or Insulin Resistance in Obesity.

Authors:  Manikandan Subramanian; Lale Ozcan; Devram Sampat Ghorpade; Anthony W Ferrante; Ira Tabas
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.